Dr. Mark Shrime is a board-certified, fellowship trained otolarynic surgeon. His academic pursuits focus on surgical delivery in low- and middle-income countries, where he has a specific interest in the intersection of health and impoverishment. His work aims to determine optimal policies and platforms for surgical delivery that maximizes health benefits while simultaneously minimizing the risk of financial catastrophe faced by patients.

Dr. Shrime was the first to identify a novel independent prognostic indicator in head and neck cancer. To date, he has worked and taught in Liberia, Sierra Leone, Guinea, Benin, Togo, Congo, Haiti, Saudi Arabia, and Madagascar.

He graduated with his medical degree from the University of Texas, after taking a year to teach organic chemistry in Singapore. Subsequently, he completed his residency in otolaryngology at the joint Columbia/Cornell program in Manhattan, followed by a fellowship in head and neck surgical oncology and in microvascular reconstructive surgery at the University of Toronto. In 2011, he graduated with an MPH in global health from the Harvard School of Public Health.